Download App

Log in to access Online Inquiry
Company Overview More
Phase Holographic Imaging PHI AB (publ) develops and markets time-lapse cytometry instrumentation and software products in Europe, Asia, and North America. The company’s products include HoloMonitor M3, a bench-top time-lapse cytometer with a motorized stage and variable magnification; and HoloMonitor M4 for time analysis of living cells directly in the incubator, as well as HoloMonitor software. Its products are used in cell growth, cell movements, cell cycle, and drug responses. The company is headquartered in Lund, Sweden.
CEO: --
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

PHI PLDT
38.170-0.360-0.93%
Post Mkt Price
38.17000.00%
YOY
Do not show
Hide blank lines
(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30
Assets
Current assets
Cash, cash equivalents and short term investments
-25.79% 29.47B -31.19% 33.42B -31.19% 33.42B -33.44% 27.12B
-Cash and cash equivalents
-17.95% 25.83B -40.58% 23.91B -40.58% 23.91B -46.28% 18.09B
-Short-term investments
-55.79% 3.64B 14.2% 9.51B 14.2% 9.51B 27.66% 9.04B
Receivables
8.52% 25.92B -1.58% 23.48B -1.58% 23.48B -13.7% 23.21B
-Accounts receivable
9.88% 24.26B -1.19% 21.79B -1.19% 21.79B -13.9% 21.51B
-Other receivables
-8.17% 1.65B -6.34% 1.69B -6.34% 1.69B -10.98% 1.7B
Inventory
-4.1% 3.96B -10.35% 3.66B -10.35% 3.66B 16.01% 4.85B
Prepaid assets
-14.81% 14.76B 19.24% 12.71B 19.24% 12.71B 69.92% 17.16B
Other current assets
381.62% 2.02B 124.61% 575M 124.61% 575M -12.15% 723M
Total current assets
-10.8% 76.25B -15.45% 73.93B -15.45% 73.93B -11.61% 73.15B
Non current assets
Net PPE
12.78% 327.31B 15.63% 322.82B 15.63% 322.82B 17.35% 310.86B
-Gross PPE
186.36% 831.07B 12.26% 815.08B 12.26% 815.08B 14.4% 788.83B
-Accumulated depreciation
-- -503.76B -10.15% -492.26B -10.15% -492.26B -12.55% -477.97B
Goodwill and other intangible assets
-2.6% 62.49B -4.28% 62.54B -4.28% 62.54B -7.04% 62.56B
-Goodwill
-- 61.38B 0% 61.38B 0% 61.38B 0% 61.38B
-Other intangible assets
-- 1.11B -70.73% 1.16B -70.73% 1.16B -80.11% 1.18B
Investments and advances
-1.74% 56.46B 1.12% 57.2B 1.12% 57.2B 1.37% 57.52B
Non current accounts receivable
-11.46% 595M -15.27% 566M -15.27% 566M -10.09% 588M
Financial assets
1033.33% 34M -- 48M -- 48M 2300% 48M
Non current deferred assets
-23.81% 11.62B -31.56% 13.39B -31.56% 13.39B -8.2% 15.94B
Non current prepaid assets
39.52% 98.04B 43.36% 94.78B 43.36% 94.78B 59.72% 90.64B
Other non current assets
198.2% 331M 26.61% 138M 26.61% 138M 14.15% 121M
Total non current assets
11.78% 557.8B 13.1% 552.4B 13.1% 552.4B 16.03% 539.17B
Total assets
8.48% 634.05B 8.77% 626.33B 8.77% 626.33B 11.85% 612.32B
Liabilities
Current liabilities
Payables
18.74% 122.59B 18.32% 113.47B 18.32% 113.47B 41.93% 109.01B
-accounts payable
-7% 85.91B 12.87% 87.64B 13.98% 87.37B 35.92% 84.63B
-Total tax payable
2659.01% 16.22B -0.88% 13.52B -5.76% 13.79B 32.32% 17.26B
-Dividends payable
4.92% 10.78B 43.05% 1.71B 43.05% 1.71B 12.83% 1.69B
-Due to related parties current
-- 167M -33.33% 200M -33.33% 200M -- 355M
-Other payable
-- 9.51B 232.96% 10.41B 232.96% 10.41B -- 5.07B
Current accrued expenses
-38.24% 65.63B -2.42% 64.89B -2.42% 64.89B -0.95% 66.29B
Current debt and capital lease obligation
97.81% 18.87B -25.8% 16.04B -25.8% 16.04B -48.78% 14.96B
-Current debt
167.31% 14.21B -34.65% 11.48B -34.65% 11.48B -58.58% 10.49B
-Current capital lease obligation
10.24% 4.65B 12.66% 4.56B 12.66% 4.56B 15.39% 4.46B
Current deferred liabilities
-- 9.4B 17.08% 10.06B 17.08% 10.06B 32.01% 10.77B
Other current liabilities
2212.15% 2.47B 1.87% 10.73B 1.87% 10.73B 5.46% 10.88B
Current liabilities
5.23% 230.61B 5.03% 224.27B 5.03% 224.27B 11.31% 221.58B
Non current liabilities
Long term provisions
-- 2.15B 6.05% 2.12B 6.05% 2.12B 24.46% 2.17B
Long term debt and capital lease obligation
11.5% 259.2B 16.74% 258.21B 16.74% 258.21B 19.36% 252.7B
-Long term debt
12.21% 242.62B 17.49% 241.08B 17.49% 241.08B 19.23% 235.47B
-Long term capital lease obligation
2.05% 16.58B 7.19% 17.13B 7.19% 17.13B 21.14% 17.23B
Non current deferred liabilities
-5.32% 6.69B 47.24% 6B 47.24% 6B 62.84% 5.72B
Non current accrued expenses
-- 80M -80.54% 300M -80.54% 300M -83.48% 364M
Employee benefits
-32.52% 7.87B -41.84% 7.76B -41.84% 7.76B 21.25% 12.27B
Derivative product liabilities
-62.75% 190M -72.22% 100M -72.22% 100M -40.43% 165M
Other non current liabilities
-- 114M -30% 105M -30% 105M -16.89% 123M
Total non current liabilities
9.77% 276.3B 13.17% 274.59B 13.17% 274.59B 19.06% 273.51B
Total liabilities
7.66% 506.91B 9.36% 498.86B 9.36% 498.86B 15.47% 495.09B
Shareholders'equity
Share capital
0% 1.6B 0% 1.6B 0% 1.6B 0% 1.6B
-common stock
0% 1.09B 0% 1.09B 0% 1.09B 0% 1.09B
-Preferred stock
0% 510M 0% 510M 0% 510M 0% 510M
Retained earnings
49.79% 34.15B 33.49% 34.24B 33.49% 34.24B 26.9% 26.74B
Paid-in capital
0% 130.31B 0% 130.31B 0% 130.31B 0% 130.31B
Less: Treasury stock
-0.31% 6.51B -0.32% 6.51B -0.32% 6.51B -0.32% 6.51B
Gains losses not affecting retained earnings
5.39% -36.68B -2.26% -36.44B -2.26% -36.44B -21.89% -39.18B
Total stockholders'equity
12.3% 122.88B 6.77% 123.22B 6.77% 123.22B -1.18% 112.97B
Noncontrolling interests
0.45% 4.27B -0.19% 4.25B -0.19% 4.25B -1.8% 4.26B
Total equity
11.86% 127.15B 6.52% 127.47B 6.52% 127.47B -1.2% 117.23B
Currency Unit
PHPPHPPHPPHP
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
--Unqualified Opinion----

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%